CELESTICA INC (CLS) earnings date, results and what the price requires
NYSE · SEC CIK 0001030894 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 27, 2026 | $4.70B | $368.8M | $3.17 | Filing |
| Mar 31, 2026 | Apr 27, 2026 | $4.05B | $212.3M | $1.83 | Filing |
| Dec 31, 2025 | Jan 28, 2026 | $3.65B | $267.5M | $2.29 | Filing |
| Sep 30, 2025 | Oct 27, 2025 | $3.19B | $267.8M | $2.31 | Filing |
| Jun 30, 2025 | Jul 28, 2025 | $2.89B | $211.0M | $1.82 | Filing |
| Mar 31, 2025 | Apr 24, 2025 | $2.65B | $86.2M | $0.74 | Filing |
| Dec 31, 2024 | Jan 29, 2025 | $2.55B | $151.7M | $1.29 | Filing |
| Sep 30, 2024 | Oct 23, 2024 | $2.50B | $89.5M | $0.75 | Filing |
What would CELESTICA INC have to report for its valuation to change?
At $303.81, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 22.0% a year, to $25.97. On that path the next quarter needs diluted EPS near $2.82, against $2.31 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 22.0% | 22.0% |
| EPS needed in final year | $25.97 | $25.97 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. CLS goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.